OBJECTIVE: This study aimed to develop a model for predicting the outcome and evaluating the treatment of patients with threatened of preterm labour. METHODS: Clinical data from 236 patients at < 32 weeks gestation who were in preterm labour were analysed to develop a discriminant function using multiple logistic regression to identify significant risk factors. The function was validated retrospectively in a further 501 patients and prospectively in 63 patients with premature labour. RESULTS: Factors that increased the risk of preterm birth were premature rupture of the membranes, intrauterine infection, dilatation of the cervix and uterine bleeding. Factors that decreased the risk of preterm birth were hospital admission after 28 weeks of gestation and intravenous administration of ritodrine. The predictive accuracy of the function was 75.4% in the 236 patients analysed, 84.8% in the further 501 retrospectively studied patients and 85.7% in the prospective group. CONCLUSIONS: The discriminant function described was clinically useful for predicting the outcome of threatened preterm labour before initiating treatment and for determining the medical care of patients, including maternal transfer to a highlevel perinatal care centre.
Introduction
Preterm birth is one of the major problems in perinatal medicine worldwide and premature labour is one of the most frequently occurring gestational disorders and a primary cause of neonatal death; in the USA, up to 75% of perinatal deaths are caused by premature birth. 1,2 Recent K Takagi, K Satoh, M Muraoka et al. Mathematical model for predicting outcome in preterm labour advances in perinatal medicine have led to marked decreases in perinatal mortality and morbidity rates, particularly in developed countries. 3 However, the rates of cerebral palsy, retinopathy and chronic respiratory disease remain high in premature infants, 4 and the long-term prognosis of prematurely delivered infants is still unknown.
Recent investigations have focused mainly on methods for predicting preterm labour, such as cervical length measurement 5, 6 and evaluation of biochemical markers such as fibronectin, 7 -11 elastase, 12 vaginal pH 13 -16 and others. 17 These studies have sought to identify high-risk subjects from within the background population. The effect of treatment with tocolytic agents, such as ritodrine hydrochloride and magnesium sulphate, on prolongation of pregnancy has been reported as not exceeding 2 -7 days. 18 -20 Thus, evaluation of the outcome of premature labour even with tocolytic therapy is important, and prediction of the prognosis before initiating treatment is clinically beneficial.
In 1974, Baumgarten and Gruber 21 described a tocolysis index for evaluation of the likelihood of preterm delivery using data from 202 preterm labour patients treated with ritodrine. In 1977, Richter 22 evaluated the correlation between the tocolysis index and the interval from initiation of treatment to delivery in 125 patients believed to have preterm labour (including those with premature rupture of the membranes), and reported that the tocolysis index had a significant negative correlation with this interval (r = −0.380, P < 0.001). However, since these reports were published there have been few further studies 23 on predicting the outcome of preterm labour. The present study proposes a mathematical model for predicting the outcome and evaluating the treatment of patients with threatened preterm labour. Data from a retrospective study were used to develop a discriminant function, which was then validated retrospectively and prospectively.
Patients and methods

RETROSPECTIVE DATA
Data from patients with gestational age < 32 weeks on hospital admission who were included in a previously reported multicentre retrospective study on the management of threatened preterm labour and the efficacy of tocolytic agents in Japan were selected for the retrospective analysis in the present study. 24 Those with a tocolysis index of 3 -6 with intravenous infusion of ritodrine which included concomitant intravenous infusion of magnesium sulphate and no tocolysis were designated as group A to create the model for predicting outcome of premature labour. The remaining patients with gestational age < 32 weeks on hospital admission, which included patients with a tocolysis index of 3 -6 who were treated with oral ritodrine, were designated as group B for predicting the external validity of the model.
With the exception of pregnant women participating in other clinical trials, all pregnant women admitted for treatment of threatened premature labour between 1 July and 31 December 1998 at one of the 37 hospitals participating in the Multicentre Premature Labour Study Group were included in the original study. 24 Patient characteristics, including age, parity, gestational age, multiple pregnancies, presence of uterine deformity, membrane rupture, presence of intrauterine infection (chorioamnionitis), polyhydramnios, uterine contraction, uterine bleeding, cervical cerclage and other complications, were recorded on admission. Intrauterine infection was diagnosed on the basis of one or more of the following findings: fever K Takagi, K Satoh, M Muraoka et al. Mathematical model for predicting outcome in preterm labour (≥ 38°C), leucocyte count > 15 000 cells/µl, Creactive protein > 2 mg/dl and positive vaginal bacterial culture. Cervical dilatation was evaluated on admission using a sterile speculum or sterile digital examination by skilled obstetricians. The tocolysis index 21 was calculated by summing the scores for uterine contraction (0, none; 1, irregular; 2, regular), ruptured membrane (0, none; 2, high leak; 4, low rupture), bleeding (0, none; 1, present) and cervical dilatation (0, closed; 1 point for each 1 cm dilatation).
The need for, selection and dose of tocolytic agents and the administration of antibiotics were determined by the obstetrician. The doses of tocolytic agents used are approved by the Health and Welfare Department of Japan as therapeutic doses (ritodrine infusion, 50 -200 µg/min; magnesium sulphate infusion, 1 -2 g/min). Clinical outcomes, including gestational age at delivery, delivery mode, Apgar score and neonatal outcome, were recorded.
PROSPECTIVE STUDY
Prospective assessment of the ability of the model to predict the outcome of premature labour was conducted from April 2005 to September 2007 at six perinatal centres in Japan (Saitama Medical University Saitama Medical Centre, Saitama, Japan; Tokyo Women's Medical University Medical Centre East, Tokyo, Japan; Aiiku Hospital, Tokyo, Japan; Juntendo University School of Medicine, Tokyo, Japan; Juntendo University Urayasu Hospital, Chiba, Japan; and Koshigaya Municipal Hospital, Saitama, Japan). Patients with clinically diagnosed threatened preterm labour at a gestational age > 22 weeks and < 32 weeks were sequentially recruited to the prospective assessment and these patients constituted group C. Exclusion criteria included previous cervical cerclage surgery and medical or obstetric complications that required early delivery of the fetus, such as severe pregnancy-induced hypertension, nonreassuring fetal states and placental abruption.
Written informed consent was obtained from all patients and they were informed that any clinical decision, such as the use of tocolytic agents or the timing and mode of delivery, would not be affected by participation in the study. Due to its observational nature, ethical approval was not required for this study.
STATISTICAL ANALYSES
Data were presented as the number and percentage of patients or the mean ± SD. Multiple logistic regression analysis was used to determine odds ratios and 95% confidence intervals to identify statistically significant risk factors for premature delivery before 32 weeks in group A. Stepwise regression analysis was then used to construct a discriminant function. Statistical analyses were performed using SAS ® version 9.1.3 statistical software (SAS Institute Inc., Cary, NC, USA). Statistical significance was set at P < 0.05.
The linear discriminant function was used to perform an internal check in group A patients and an external check in group B patients, and was applied to group C patients to predict the outcome of premature labour. The validity (true positive + true negative results), sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of the discriminant function were calculated for all three groups.
Results
Of the 1147 patients included in the original multicentre report, 24 737 had a gestational age of < 32 weeks on hospital admission. Those with a tocolysis index of 3 -6 with K Takagi, K Satoh, M Muraoka et al.
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intravenous infusion of ritodrine which included concomitant intravenous infusion of magnesium and no tocolysis were allocated to group A (n = 236) to create the model for predicting the outcome of premature labour. The remaining patients with gestational age < 32 weeks on hospital admission were allocated to group B (n = 501), which included patients with a tocolysis index of 3 -6 who were treated with ritodrine, for predicting the external validity of the model. A total of 63 patients with clinically diagnosed threatened preterm labour at a gestational age > 22 weeks and < 32 weeks, including 12 cases with premature rupture of the membranes, were included in group C for prospective assessment of the ability of the model to predict the outcome of premature labour. The characteristics of all three groups of patients are shown in Table 1 .
Adjusted odds ratios indicated that the factors significantly (P < 0.05) associated with increased risk of preterm birth in group A Data presented as number of patients (%) or mean ± SD.
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were ruptured membranes, intrauterine infection, dilatation of the cervix and uterine bleeding, while those significantly (P < 0.05) associated with decreased risk were gestational age at admission (> 28 weeks) and the administration of intravenous ritodrine ( Table 2 ). Maternal age, presence of uterine contractions, multiple pregnancies, cervical cerclage surgery, administration of antibiotics, magnesium sulphate infusion and polyhydramnios were not significantly associated with the risk of preterm birth.
The statistically significant factors identified on multiple logistic regression were subjected to stepwise regression analysis to construct the linear discriminant function: 2.125A -1.616B -1.055C -1.008D -0.937E + 0.173F -3.873, where A is ritodrine infusion (0, no; 1, yes), B is intrauterine infection (0, no; 1, yes), C is premature rupture of membranes (0, no; 2, high leak; 4, low rupture), D is uterine bleeding (0, none; 1, spotting; 2, bleeding), E is cervical dilatation (0, closed; 1, 1 cm dilated; 2, 2 cm dilated; 3, 
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3 cm dilated; 4, ≥ 4 cm dilated) and F is gestational age at admission ≥ 28 weeks (0, no; 1, yes). When the value calculated by the function was > 0, the pregnancy was expected to continue beyond 32 weeks.
The validity, sensitivity, specificity, PPV and NPV of the discriminant function in groups A, B and C are shown in Table 3 .
Discussion
The rate of premature births is increasing annually in Japan, rising from 4.1% in 1980 to 5.7% in 2009. 25 Similar trends have been reported in other countries, 16 despite the efforts of obstetricians to prevent premature births. Recent management practices for premature labour have focused on identifying and treating high-risk populations; however, confusion regarding the efficacy and safety of tocolytic agents has resulted in the prospects for long-term prolongation of pregnancy in preterm labour cases being disappointing.
The tocolytic agents ritodrine hydrochloride and magnesium sulphate were once commonly utilized worldwide and are approved by the Health and Welfare Department of Japan, but are no longer used in many countries. The efficacy of ritodrine hydrochloride in prolonging pregnancy has recently been reported, 19 but there were no significant improvements in neonatal survival rate or neonatal morbidity measurements such as respiratory distress syndrome and Apgar score at 5 min ≤ 6. In the present study, the use of ritodrine significantly lowered the risk of premature delivery, but the use of magnesium sulphate and antibiotics did not. Factors increasing the risk of premature delivery were ruptured membranes, intrauterine infection, uterine bleeding and cervical dilatation. The analysis in the present study concerned only patients with a gestational age < 32 weeks because the standard survival rate for neonates approaches 100% at gestational ages ≥ 32 weeks in most neonatal intensive care units. 26 The discriminant function constructed in the present study was useful for predicting the likelihood of preterm delivery and, consequently, may make an important contribution to perinatal medicine by helping clinical staff to decide the timing of maternal transfer or the preparation of an on-site neonatal intensive care unit. The validity of this model appears to be sufficient for clinical use. In the process of developing it, many clinical factors that were excluded in other studies, such as multiple pregnancies, cervical cerclage surgery, polyhydramnios, intrauterine infection and ruptured membranes, were included in the analysis to extract significant risk factors. Thus, this model can be used to predict the prognosis of a pregnancy complicated by premature labour in most clinical situations.
Sensitivity and PPV were higher and specificity and NPV were lower in groups B and C than in group A. The overall low specificity and NPV remain problems to be resolved, however, from a clinical viewpoint it is more important to identify patients whose pregnancies can be prolonged with proper tocolytic therapy.
In a recent study, levels of 27 cervical and amniotic fluid proteins were measured in 89 women in preterm labour between 22 and 33 weeks of pregnancy with intact membranes, in an attempt to predict those who would deliver within 7 days of sampling. 27 The study reported two multivariate models: (i) a combined multivariate prediction model based on amniotic macrophage inflammatory protein-1β, cervical interferon-γ and monocyte chemotactic protein-1, and (ii) an alternative model based on cervical length, cervical interferon-γ, interleukin-6 and monocyte chemotactic protein-1. The former model • Received for publication 7 February 2012 • Accepted subject to revision 4 March 2012
• Revised accepted 1 June 2012 Copyright © 2012 Field House Publishing LLP predicted outcomes with 91% sensitivity, 84% specificity, 78% PPV and 94% NPV, and the latter predicted outcomes with 85% sensitivity, 82% specificity, 74% PPV and 90% NPV. 27 Compared with the results of the present study, these models showed similar levels of sensitivity and PPV but higher specificity and NPV. However, measuring these proteins is an expensive process, and there is a time delay between specimen sampling and decision making. Furthermore, Holst et al. 27 did not report on the use of medications, including tocolytic agents. The method presented in the current study is simple and facilitates quick decision making.
In conclusion, the discriminant function described in the present study was clinically useful for predicting the prognosis of threatened preterm labour before initiating treatment and for determining the medical care of patients, including maternal transfer to a high-level perinatal care centre.
